Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

The field of epilepsy research has rapidly evolved with an appreciation that seizures arise from dysfunctions in distributed ...

Introduction Mental disorders affect nearly one billion people worldwide, posing major challenges to public health. While conventional treatments like psychotherapy and pharmacotherapy are effective ...

While visual training will likely continue to be a productive part of treatment for people with hemianopia, the EPFL study ...

Dyslexia is a common developmental disorder, affecting around 7% of the global population. It is characterized by ...

A new brain device from Northwestern University is asking a daring question: what if information could reach your brain ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

The US FDA has approved the FL-100, the first at-home brain-stimulation device for treating moderate to severe major depressive disorder, following successful trials.

This exploratory study in healthy young adults found that plasma sodium levels within the normal clinical range are ...

Anxiety is often described as a whole‑brain problem, but a series of mouse experiments suggests that, in some cases, a single ...